Genetic analysis of common triazole resistance mechanisms in a collection of Aspergillus lentulus clinical isolates from the United States
Antimicrobial Agents and Chemotherapy · 2025
DOI: 10.1128/aac.00690-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Adela Martin-Vicente und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Triazoles, Antifungal Agents, Aspergillus, Drug Resistance, Fungal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Aspergillus fumigatus continues to be the leading cause of invasive aspergillosis. However, the number of cases by drug-resistant cryptic species has increased in recent years. Aspergillus lentulus is a sibling species of Aspergillus section Fumigati that can only be distinguished from A. fumigatus by molecular methods. The clinical importance of this species resides in its low susceptibility to triazoles and intrinsic resistance to amphotericin B, making invasive aspergillosis treatments extremely challenging and producing high mortality rates. In this study, we investigate known molecular mechanisms important for triazole resistance in A. fumigatus in a collection of 25 clinical A. lentulus isolates from the United States. Using CRISPR-Cas9 gene editing technology, we performed cyp51A and hmg1 allele replacements between susceptible and resistant isolates. Phenotypic characterization of the resulting mutants, together with mRNA expression analyzes of cyp51A , cyp51B, and the putative ABC efflux pump, abcC , suggests that triazole resistance in our A. lentulus isolates is independent of the mechanisms studied.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
- Department of Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
- Graduate Program in Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
- Department of Agronomy, Biotechnology and Food, University of Navarra, Pamplona, Spain.
- Department of Microbiology, Immunology, and Biochemistry, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
ORCID-Profile: Adela Martin-Vicente, Jarrod R Fortwendel
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Martin-Vicente, A., Nywening, A. V., Xie, J., Thorn, H. I., Guruceaga, X., & Fortwendel, J. R. (2025). Genetic analysis of common triazole resistance mechanisms in a collection of Aspergillus lentulus clinical isolates from the United States. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00690-25
Vancouver
Martin-Vicente A, Nywening AV, Xie J, Thorn HI, Guruceaga X, Fortwendel JR. Genetic analysis of common triazole resistance mechanisms in a collection of Aspergillus lentulus clinical isolates from the United States. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00690-25
BibTeX
@article{MartinVicente2025,
author = {Martin-Vicente, Adela and Nywening, Ashley V and Xie, Jinhong and Thorn, Harrison I and Guruceaga, Xabier and Fortwendel, Jarrod R},
title = {Genetic analysis of common triazole resistance mechanisms in a collection of Aspergillus lentulus clinical isolates from the United States},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
doi = {10.1128/aac.00690-25}
}
EUVIMED